CYTELIUM Trademark

Trademark Overview


On Thursday, April 4, 1996, a trademark application was filed for CYTELIUM with the United States Patent and Trademark Office. The USPTO has given the CYTELIUM trademark a serial number of 75083812. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 23, 1997. This trademark is owned by PIERRE FABRE MEDICAMENT S.A.. The CYTELIUM trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in dermatology

General Information


Serial Number75083812
Word MarkCYTELIUM
Filing DateThursday, April 4, 1996
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, September 23, 1997
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations for use in dermatology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, August 4, 1999
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePIERRE FABRE MEDICAMENT S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address92100 Boulogne
FR

Trademark Events


Event DateEvent Description
Tuesday, September 23, 1997ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, February 10, 1997FINAL REFUSAL MAILED
Monday, December 9, 1996CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 26, 1996NON-FINAL ACTION MAILED
Monday, September 9, 1996ASSIGNED TO EXAMINER